+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity

The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity

Frontiers in Immunology 4: 490

Considerable evidence has been gathered over the last 10 years showing that the tumor microenvironment (TME) is not simply a passive recipient of immune cells, but an active participant in the establishment of immunosuppressive conditions. It is now well documented that hypoxia, within the TME, affects the functions of immune effectors including natural killer (NK) cells by multiple overlapping mechanisms. Indeed, each cell in the TME, irrespective of its transformation status, has the capacity to adapt to the hostile TME and produce immune modulatory signals or mediators affecting the function of immune cells either directly or through the stimulation of other cells present in the tumor site. This observation has led to intense research efforts focused mainly on tumor-derived factors. Notably, it has become increasingly clear that tumor cells secrete a number of environmental factors such as cytokines, growth factors, exosomes, and microRNAs impacting the immune cell response. Moreover, tumor cells in hostile microenvironments may activate their own intrinsic resistance mechanisms, such as autophagy, to escape the effective immune response. Such adaptive mechanisms may also include the ability of tumor cells to modify their metabolism and release several metabolites to impair the function of immune cells. In this review, we summarize the different mechanisms involved in the TME that affect the anti-tumor immune function of NK cells.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056277611

Download citation: RISBibTeXText

PMID: 24400010

DOI: 10.3389/fimmu.2013.00490

Related references

Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity. Oncotarget 7(27): 42195-42207, 2016

A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8 + T cell-mediated anti-tumor immunity. Biomaterials 205: 94, 2019

Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4+ T Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor Microenvironment Toward an Anti-Tumor State. Frontiers in Oncology 4: 32, 2014

Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress. Frontiers in Immunology 6: 482, 2015

Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. International Journal of Hyperthermia 24(1): 41-56, 2008

An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. Journal of Experimental Medicine 188(9): 1611-1619, 1998

Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1. Cancer Immunology ImmunoTherapy 62(10): 1637-1648, 2013

Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity. Frontiers in Immunology 3: 187, 2012

Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity. Cancer Immunology ImmunoTherapy 58(7): 1057-1069, 2009

Production of interleukin-2 EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity. Journal of Immunotherapy With Emphasis on Tumor Immunology 15(2): 119-128, 1994

Anti-tumor immunity and mechanism of immunosuppression mediated by tumor cells: role of tumor-derived soluble factors and cytokines. International Reviews of Immunology 29(4): 421-458, 2010

Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity. Frontiers in Immunology 9: 314, 2018

Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination. Experimental & Molecular Medicine 36(5): 428-443, 2004

Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells. Breast Cancer Research & Treatment 60(2): 129-134, 2000

The chemokine CKbeta-11/MIP-3beta/ELC/Exodus III generates anti-tumor activity through natural killer cells and anti-tumor immunity through CD4+ cells. Blood 94(10 Suppl. 1 Part 1): 362a, 1999